TickerFactsScreenerDevelopers

Xenon Pharmaceuticals Inc. (XENE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $526.0K2013: $156.0K2014: $1.53M2015: $551.0K2016: $279.0K2017: $315.0K2018: $507.0K2019: $1.24M2020: $2.64M2021: $2.05M2022: $2.89M2023: $5.62M2024: $3.08M2025: $799.0K$799.0K
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$799.0K-74.0%
2024$3.08M-45.3%
2023$5.62M+94.1%
2022$2.89M+41.2%
2021$2.05M-22.3%
2020$2.64M+112.7%
2019$1.24M+144.6%
2018$507.0K+61.0%
2017$315.0K+12.9%
2016$279.0K-49.4%
2015$551.0K-64.0%
2014$1.53M+880.1%
2013$156.0K-70.3%
2012$526.0K—